Picture of AbCellera Biologics logo

ABCL — AbCellera Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

AbCellera up on partnership with AbbVie for antibody therapies

** AbCellera Biologics Inc's shares  ABCL.O  up 4.7% at
$10.61 premarket
    ** ABCL has entered into collaboration with AbbVie Inc
 ABBV.N  to advance new antibody therapies  urn:newsml:reuters.com:*:nBw17m0zHa
    ** Under the agreement, ABBV has the right to develop and
commercialize therapeutic antibodies resulting from the
collaboration
    ** ABCL will receive research payments and is eligible to
receive downstream clinical and commercial milestone payments
and royalties on net sales of products
    ** Up to Wednesday's close, stock had fallen ~29% YTD 
 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))

Recent news on AbCellera Biologics

See all news